At a glance
This program funds a multidisciplinary research program with at least two and no more than three complementary projects focused on an overarching question about rare melanomas. Eligible applicants include U.S. Department of War extramural and intramural organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; awards are made to organizations, not individuals. The total cost cap is $2.8 million per award, with about two awards expected, and the period of performance is up to 4 years. Cost sharing is not required. The announcement says there are no geographic restrictions, but the research team must include at least one rare melanoma survivor or patient advocate, and studies on non-melanoma skin cancers are not allowed.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas. Distinctive Features: · *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact. · This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1 . Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). · After submitting the required pre-application, investigators must receive an invitation to submit a full application . Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project. · Clinical trials are allowed.
Who can apply
- Unrestricted